Pacer iPath Gold ETNs
GBUG
GBUG was delisted on the 14th of December, 2022.
0 hedge funds and large institutions have $0 invested in Pacer iPath Gold ETNs in 2022 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, reducing their positions, and 4 closing their positions.
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $32.3M → $0 (-$32.3M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 4
Top Buyers
Top Sellers
| 1 |
Barclays
London,
United Kingdom
|
-$27.1M |
| 2 |
MWM
Marion Wealth Management
Monroeville,
Pennsylvania
|
-$4.34M |
| 3 |
IMC Chicago
Chicago,
Illinois
|
-$755K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$4K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Barclays
London,
United Kingdom
| – | -$27.1M | -1,000,000 | Closed |
|
|
MWM
2
Marion Wealth Management
Monroeville,
Pennsylvania
| – | -$4.34M | -159,982 | Closed |
|
|
3
IMC Chicago
Chicago,
Illinois
| – | -$755K | -27,811 | Closed |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$4K | -133 | Closed |
|
GBUG Hedge Fund Activity: Q4 2022 in Review
0 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Pacer iPath Gold ETNs (GBUG) for Q4 2022, worth a combined $0 — down 100% from $32.3M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of GBUG and 0 opened new positions — a net loss of 4 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Barclays, exiting entirely with an estimated $27.1M sold.
- 0 institutional investors held Pacer iPath Gold ETNs (GBUG) as of Q4 2022, down from 5 in Q3 2022.
- Funds reported $0 of Pacer iPath Gold ETNs stock for Q4 2022, down 100% quarter-over-quarter.
- 0 funds opened new Pacer iPath Gold ETNs positions in Q4 2022 and 4 closed out, a net change of -4 holders.
- The largest Pacer iPath Gold ETNs seller in Q4 2022 was Barclays, an estimated $27.1M sold.
Based on aggregated 13F filings for Q4 2022.